bendamustine hydrochloride has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abi Hatem, N; Dameron, M; Gupta, N; Horowitz, M | 1 |
| Bosanquet, N; Crawford, R; Doward, L; Lay-Flurrie, J; Leather, D; Svedsater, H; Whalley, D | 1 |
1 trial(s) available for bendamustine hydrochloride and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations.
Topics: Aged; Androstadienes; Bendamustine Hydrochloride; Benzyl Alcohols; Chlorobenzenes; Female; Follow-Up Studies; Glucocorticoids; Humans; Interviews as Topic; Male; Pulmonary Disease, Chronic Obstructive; Quality of Life; Symptom Flare Up | 2019 |
1 other study(ies) available for bendamustine hydrochloride and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients.
Topics: Aged; Anti-Bacterial Agents; Bendamustine Hydrochloride; HIV Seronegativity; Humans; Immunocompromised Host; Lung Diseases, Interstitial; Lymphoma, Mantle-Cell; Male; Opportunistic Infections; Pneumonia, Pneumocystis; Prednisone; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Rituximab; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |